Q. Weng et al. / European Journal of Pharmacology 581 (2008) 262–269
269
Hayward, R.L., Macpherson, J.S., Cummings, J., Monia, B.P., Smyth, J.F., Jodrell,
D.I., 2004. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl
down-regulation is p53 and Bax dependent, Genetic evidence for specificity of
the antisense effect. Mol. Cancer Ther. 3, 169–178.
Ivanovic, Z., Belloc, F., Faucher, J.L., Cipolleschi, M.G., Praloran, V., Dello Sbarba,
P., 2002. Hypoxia maintains and interleukin-3 reduces the pre-colony-forming
cell potential of dividing CD34+ murine bone marrow cells. Exp. Hematol. 30,
67–73.
selective agents derived from 2-quinoxalinecarbonitrile 1, 4-di-N-oxides.
J. Med. Chem. 38, 4488–4494.
Monge, A., Palop, J.A., López de Ceráin, A., Senador, V., Martínez-Crespo, F.J.,
Sainz, Y., Narro, S., García, E., de Miguel, C., González, M., 1995b. Hypoxia-
selective agents derived from Quinoxaline 1 ,4-di-N-oxides. J. Med. Chem. 38,
1786–1792.
Nozaki, K., Nishimura, M., Hashimoto, N., 2001. Mitogen-activated protein
kinases and cerebral ischemia. Mol. Neurobiol. 23, 1–19.
Katiyar, S.K., Roy, A.M., Baliga, M.S., 2005. Silymarin induces apoptosis
primarily through a p53-dependent pathway involving Bcl-2/Bax, cyto-
chrome C release, and caspase activation. Mol. Cancer Ther. 4, 207–216.
Ke, Q., Costa, M., 2006. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol.
70, 1469–1480.
Ogbourne, S.M., Suhrbier, A., Jones, B., Cozzi, S.J., Boyle, G.M., Morris, M.,
McAlpine, D., Johns, J., Scott, T.M., Sutherland, K.P., Gardner, J.M., Le, T.T.,
Lenarczyk, A., Aylward, J.H., Parsons, P.G., 2004. Antitumor activity of 3-
ingenyl angelate, plasma membrane and mitochondrial disruption and necrotic
cell death. Cancer Res. 64, 2833–2839.
Koukourakis, M.I., Giatromanolaki, A., Sivridis, E., Simopoulos, C., Turley, H.,
Talks, K., Gatter, K.C., Harris, A.L., 2002. Hypoxia-inducible factor (HIF1A
and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous
cell head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 53, 1192–1202.
Lee, S.R., Lo, E.H., 2003. Interactions between p38 mitogen-activated protein kinase
and caspase-3 in cerebral endothelial cell death after hypoxia-reoxygenation.
Stroke 34, 2704–2709.
Le-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F., Green, D.R., Karin, M.,
1999. Withdrawal of survival factors results in activation of the JNK
pathway in neuronal cells leading to Fas ligand induction and cell death.
Mol. Cell Biol. 19, 751–763.
Lewis, T.S., Shapiro, P.S., Ahn, N.G., 1998. Signal transduction through MAP
kinase cascades. Adv. Cancer Res. 74, 49–139.
Luo, J., Sun, Y., Lin, H., Qian, Y., Li, Z., Leonard, S.S., Huang, C., Shi, X.,
2003. Activation of JNK by vanadate induces a Fas-associated death domain
(FADD)-dependent death of cerebellar granule progenitors in vitro. J. Biol.
Chem. 278, 4542–4551.
Mancini, M., Anderson, B.O., Caldwell, E., Sedghinasab, M., Paty, P.B.,
Hockenbery, D.M., 1997. Mitochondrial proliferation and paradoxical mem-
brane depolarization during terminal differentiationand apoptosis in a human
colon carcinoma cell line. J. Cell Biol. 138, 449–469.
Maurer, B.J., Metelitsa, L.S., Seeger, R.C., Cabot, M.C., Reynolds, C.P.,
1999. Increase of ceramide and induction of mixed apoptosis/necrosis by
N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines. J. Natl.
Cancer Inst. 91, 1138–1146.
Milella, M., Kornblau, S.M., Estrov, Z., Carter, B.Z., Lapillonne, H., Harris, D.,
Konopleva, M., Zhao, S., Estey, E., Andreeff, M., 2001. Therapeutic targeting
of the MEK/MAPK signal transduction module in acute myeloid leukemia.
J. Clin. Invest. 108, 851–859.
Minamino, T., Yujiri, T., Papst, P.J., Chan, E.D., Johnson, G.L., Terada, N., 1999.
MEKK1 suppresses oxidative-stress induced apoptosis of embryonic stem cell
derived cardiac myocytes. Proc. Natl. Acad. Sci. U S A. 96, 15127–15132.
Minden, A., Karin, M., 1997. Regulation and function of the JNK subgroup of
MAP kinases. Biochim. Biophys. Acta 1333, 85–104.
Rice, P.L., Washington, M., Schleman, S., Beard, K.S., Driggers, L.J., Ahnen,
D.J., 2003. Sulindac sulfide inhibits epidermal growth factor-induced
phosphorylation of extracellular-regulated kinase 1/2 and Bad in human
colon cancer cells. Cancer Res. 63, 616–620.
Rotem, R., Heyfets, A., Fingrut, O., Blickstein, D., Shaklai, M., Flescher, E.,
2005. Jasmonates, novel anticancer agents acting directly and selectively on
human cancer cell mitochondria. Cancer Res. 65, 1984–1993.
Ryan, H.E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J.M.,
Johnson, R.S., 2000. Hypoxia inducible factor-α1 is a positive factor in solid
tumor growth. Cancer Res. 60, 4010–4015.
Semenza, G.L., 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3,
721–732.
Sinicrope, F.A., Penington, R.C., 2005. Sulindac sulfide-induced apoptosis is
enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human
colon cancer cells overexpressing Bcl-2. Mol. Cancer Ther. 4, 1475–1483.
Sohda, M., Ishikawa, H., Masuda, N., Kato, H., Miyazaki, T., Nakajima, M.,
Fukuchi, M., Manda, R., Fukai, Y., Sakurai, H., Kuwano, H., 2004. Pretreatment
evaluation of combined HIF-1α, p53 and p21 expression is a useful and sensitive
indicator of response to radiation and chemotherapy in esophageal cancer. Int.
J. Cancer 110, 838–844.
Tang, L., Zhang, Y., 2005. Mitochondria are the primary target in isothiocyanate-
induced apoptosis in human bladder cancer cells. Mol. Cancer Ther. 4,
1250–1259.
Wouters, B.G., Delahoussaye, Y.M., Evans, J.W., Birrell, G.W., Dorie, M.J.,
Wang, J., MacDermed, D., Chiu, R.K., Brown, J.M., 2001. Mitochondrial
dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.
Cancer Res. 61, 145–152.
Wu, C.C., Chan, M.L., Chen, W.Y., Tsai, C.Y., Chang, F.R., Wu, Y.C., 2005.
Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via
direct effects on mitochondria. Mol. Cancer Ther. 4, 1277–1285.
Yamanaka, K., Rocchi, P., Miyake, H., Fazli, L., Vessella, B., Zangemeister-
Wittke, U., Gleave, M.E., 2005. A novel antisense oligonucleotide inhibiting
several antiapoptotic Bcl-2 family members induces apoptosis and enhances
chemosensitivity in androgen-independent human prostate cancer PC3 cells.
Mol. Cancer Ther. 4, 1689–1698.
Zhang, Q., Oh, C.K., Messadi, D.V., Duong, H.S., Kelly, A.P., Soo, C., Wang,
L., Le, A.D., 2006. hypoxia-induced HIF-1alpha accumulation is augmented
in a co-culture of keloid fibroblasts and human mast cells: involvement of
ERK1/2 and PI-3K/Akt. Exp. Cell Res. 312, 145–155.
Miranda, M.B., Dyer, K.F., Grandis, J.R., Johnson, D.E., 2003. Differential
activation of apoptosis regulatory pathways during monocytic vs granulo-
cytic: a requirement for Bcl-XL and XIAP in the prolonged survival of
monocytic cells. Leukemia 17, 390–400.
Monge, A., Martínez-Crespo, F.J., López de Ceráin, A., Palop, J.A., Narro, S.,
Senador, V., Marín, A., Sainz, Y., González, M., Hamilton, E., 1995a. Hypoxia-